Cargando…

Pharmacogenetic drug use in young danish individuals with severe mental disorders

INTRODUCTION: Pharmacogenetics (PGx) studies genetic variance and related differences in drug outcomes. PGx guidelines for psychotropic drugs are available (PGx drugs), but PGx testing is used only limitedly in psychiatric clinical practice. OBJECTIVES: The aim of this study is to pinpoint different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lunenburg, C., Ishtiak-Ahmed, K., Werge, T., Gasse, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471862/ http://dx.doi.org/10.1192/j.eurpsy.2021.394

Ejemplares similares

Pharmacogenetic profiles of young danish individuals with and without severe mental disorders
por: Lunenburg, C., et al.
Publicado: (2021)

Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
por: Lunenburg, C., et al.
Publicado: (2021)

Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark
por: Lunenburg, Carin A.T.C., et al.
Publicado: (2021)

Pharmacogenetic CYP2D6 variability, phenoconversion and treatment outcomes: A Danish population-based cohort study in 6,798 individuals initiating atomoxetine treatment
por: Ishtiak-Ahmed, K., et al.
Publicado: (2022)

Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
por: Mushtaq, M., et al.
Publicado: (2022)

Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study
por: Thiele, L., et al.
Publicado: (2022)

Primary Care Prescription Drug Use and Related Actionable Drug‐Gene Interactions in the Danish Population
por: Lunenburg, Carin Adriana Theodora Catharina, et al.
Publicado: (2020)

Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2021)

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study
por: Thiele, Liv S., et al.
Publicado: (2022)

The effectiveness of involuntary electroconvulsive therapy (ECT): A population-based study
por: Salagre, E., et al.
Publicado: (2021)

O4.6. GENOME-WIDE ASSOCIATION STUDY, HERITABILITY ESTIMATION AND POLYGENIC RISK ANALYSIS OF SUSCEPTIBILITY TO INFECTIONS IN 65,534 INDIVIDUALS WITH SEVERE MENTAL DISORDERS AND POPULATION CONTROLS
por: Benros, Michael, et al.
Publicado: (2018)

Individual placement and support in young people with severe mental illness: an Italian experience
por: Pelizza, L.
Publicado: (2022)

Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders
por: Blasco-Fontecilla, Hilario
Publicado: (2018)

Compensation Possibilities of Mental Disorders — Individual Case of a Child with Severe Neurological Disorder
por: Fedorova, Y., et al.
Publicado: (2022)

T229. ANTIPSYCHOTIC DRUG USE AND THYROID FUNCTION IN PATIENTS WITH SEVERE MENTAL DISORDERS
por: Iversen, Trude, et al.
Publicado: (2018)

Treatment indications and potential off‐label use of antidepressants among older adults: A population‐based descriptive study in Denmark
por: Ishtiak‐Ahmed, Kazi, et al.
Publicado: (2022)

Predictors of suicidal behaviour in 36,304 individuals sickness absent due to stress-related mental disorders - a Swedish register linkage cohort study
por: Ishtiak-Ahmed, Kazi, et al.
Publicado: (2013)

Is there a dose-response relationship between cannabis use and violence? A longitudinal study in individuals with severe mental disorders
por: Beaudoin, M., et al.
Publicado: (2023)

Risk markers of all-cause and diagnosis-specific disability pension - a prospective cohort study of individuals sickness absent due to stress-related mental disorders
por: Ishtiak-Ahmed, Kazi, et al.
Publicado: (2014)

The prevalence of mental disorders among young people in europe
por: Sacco, R., et al.
Publicado: (2021)

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
por: Perwitasari, D. A., et al.
Publicado: (2011)

2107. Azole Therapeutic Drug Monitoring (TDM) in a Multiracial Cohort with Varied Pharmacogenetics
por: Yvonne Zhou, Peijun, et al.
Publicado: (2019)

EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023)

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy
por: Salvadori, Maurizio, et al.
Publicado: (2020)

O5.3. A COMPREHENSIVE NATIONWIDE STUDY OF COMORBIDITY WITHIN TREATED MENTAL DISORDERS – A DANISH REGISTER-BASED STUDY
por: Ripoll, Oleguer Plana, et al.
Publicado: (2018)

T3. METACOGNITIVE BELIEFS IN SEVERE MENTAL DISORDERS
por: Østefjells, Tiril, et al.
Publicado: (2018)

Cognitive decline and psychotropic drugs use in elderly people with mental disorders
por: De Oliveira, K. Cestari, et al.
Publicado: (2021)

Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in sweden during the early months of the outbreak
por: Werneke, U., et al.
Publicado: (2021)

Pharmacogenetics of analgesic drugs
por: Cregg, Roman, et al.
Publicado: (2013)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005)

Management of diabetes mellitus in patients with severe mental disorders using new generation hypoglycemic drugs- A review of the literature
por: Vasiliu, O.
Publicado: (2023)

Pharmacogenetics of Anti-Diabetes Drugs
por: DiStefano, Johanna K., et al.
Publicado: (2010)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

T3 Pharmacogenetic Gene-drug Associations in Pediatric Burn and Surgery Patients
por: Grimsrud, Kristin N, et al.
Publicado: (2022)

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019)

A large-scale genomic investigation of susceptibility to infection and its association with mental disorders in the Danish population
por: Nudel, Ron, et al.
Publicado: (2019)

Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)

Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
por: Ter Hark, S., et al.
Publicado: (2023)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vl80hee9dg58lu8thea2dsmv9b